255
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Imidazole Propionate is Increased in Diabetes and Associated with Stool Consistency

, , , &
Pages 1715-1724 | Published online: 07 Jun 2022

References

  • Pedersen HK, Gudmundsdottir V, Nielsen HB, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535(7612):376–381. doi:10.1038/nature18646
  • Jia W, Wei M, Rajani C, Zheng X. Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein Cell. 2020. doi:10.1007/s13238-020-00804-9
  • Burton JH, Johnson M, Johnson J, Hsia DS, Greenway FL, Heiman ML. Addition of a gastrointestinal microbiome modulator to metformin improves metformin tolerance and fasting glucose levels. J Diabetes Sci Technol. 2015;9(4):808–814. doi:10.1177/1932296815577425
  • Bogachev AV, Bertsova YV, Bloch DA, Verkhovsky MI. Urocanate reductase: identification of a novel anaerobic respiratory pathway in Shewanella oneidensis MR-1. Mol Microbiol. 2012;86(6):1452–1463. doi:10.1111/mmi.12067
  • Koh A, Molinaro A, Stahlman M, et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell. 2018;175(4):947–61 e17. doi:10.1016/j.cell.2018.09.055
  • Koh A, Manneras-Holm L, Yunn NO, et al. Microbial imidazole propionate affects responses to metformin through p38gamma-dependent inhibitory AMPK phosphorylation. Cell Metab. 2020;32(4):643–53e4. doi:10.1016/j.cmet.2020.07.012
  • Cani PD. Microbiota and metabolites in metabolic diseases. Nat Rev Endocrinol. 2019;15(2):69–70. doi:10.1038/s41574-018-0143-9
  • Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. doi:10.1038/s41579-020-0433-9
  • Wu H, Tremaroli V, Schmidt C, et al. The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study. Cell Metab. 2020;32(3):379–90 e3. doi:10.1016/j.cmet.2020.06.011
  • Molinaro A, Bel Lassen P, Henricsson M, et al. Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology. Nat Commun. 2020;11(1):5881. doi:10.1038/s41467-020-19589-w
  • Van der Heiden C, Wadman SK, de Bree PK, Wauters EA. Increased urinary imidazolepropionic acid, N-acetylhistamine and other imid azole compounds in patients with intestinal disorders. Clin Chim. 1972;39(1):201–214. doi:10.1016/0009-8981(72)90317-8
  • Yamamoto M, Pinto-Sanchez MI, Bercik P, Britz-McKibbin P. Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients. Metabolomics. 2019;15(6):82. doi:10.1007/s11306-019-1543-0
  • Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut. 2016;65(1):57–62. doi:10.1136/gutjnl-2015-309618
  • Yap CX, Henders AK, Alvares GA, et al. Autism-related dietary preferences mediate autism-gut microbiome associations. Cell. 2021;184(24):5916–31 e17. doi:10.1016/j.cell.2021.10.015
  • Bunnett NW. Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract. J Physiol. 2014;592(14):2943–2950. doi:10.1113/jphysiol.2014.271155
  • Alemi F, Poole DP, Chiu J, et al. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology. 2013;144(1):145–154. doi:10.1053/j.gastro.2012.09.055
  • Vijayvargiya P, Camilleri M, Burton D, Busciglio I, Lueke A, Donato LJ. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome. Aliment Pharmacol Ther. 2019;49(6):744–758. doi:10.1111/apt.15106
  • Vuong HE, Pronovost GN, Williams DW, et al. The maternal microbiome modulates fetal neurodevelopment in mice. Nature. 2020;586(7828):281–286. doi:10.1038/s41586-020-2745-3
  • Tanes C, Bittinger K, Gao Y, et al. Role of dietary fiber in the recovery of the human gut microbiome and its metabolome. Cell Host Microbe. 2021;29(3):394–407 e5. doi:10.1016/j.chom.2020.12.012
  • Chen PB, Black AS, Sobel AL, et al. Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis. Nat Biotechnol. 2020;38(11):1288–1297. doi:10.1038/s41587-020-0549-5
  • Camilleri M, Vijayvargiya P. The role of bile acids in chronic diarrhea. Am J Gastroenterol. 2020;115(10):1596–1603. doi:10.14309/ajg.0000000000000696
  • Misawa N, Higurashi T, Takatsu T, et al. The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota. Aliment Pharmacol Ther. 2020;52(5):821–828. doi:10.1111/apt.15950
  • Von Schwartzenberg RJ, Bisanz JE, Lyalina S, et al. Caloric restriction disrupts the microbiota and colonization resistance. Nature. 2021;595(7866):272–277. doi:10.1038/s41586-021-03663-4
  • Tian Y, Gui W, Koo I, et al. The microbiome modulating activity of bile acids. Gut Microbes. 2020;11(4):979–996. doi:10.1080/19490976.2020.1732268
  • Wang L, Gong Z, Zhang X, et al. Gut microbial bile acid metabolite skews macrophage polarization and contributes to high-fat diet-induced colonic inflammation. Gut Microbes. 2020;12(1):1–20. doi:10.1080/19490976.2020.1819155
  • Wang S, Martins R, Sullivan MC, et al. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids. Microbiome. 2019;7(1). doi:10.1186/s40168-019-0740-4
  • Worthmann A, John C, Ruhlemann MC, et al. Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis. Nat Med. 2017;23(7):839–849. doi:10.1038/nm.4357
  • Van Best N, Rolle-Kampczyk U, Schaap FG, et al. Bile acids drive the newborn’s gut microbiota maturation. Nat Commun. 2020;11(1):3692. doi:10.1038/s41467-020-17183-8
  • Hornef ARKHAWNBM, Hassani K, Walker A. Disturbed gut microbiota and bile homeostasis in Giardia -infected mice contributes to metabolic dysregulation and growth impairment. Sci Transl Med. 2020;12(565):7019. doi:10.1126/scitranslmed.aay7019
  • Hibberd AA, Yde CC, Ziegler ML, et al. Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults. Benef Microbes. 2019;10(2):121–135. doi:10.3920/BM2018.0028
  • Allada R, Bass J, Longo DL. Circadian mechanisms in medicine. N Engl J Med. 2021;384(6):550–561. doi:10.1056/NEJMra1802337
  • Wilmanski T, Rappaport N, Earls JC, et al. Blood metabolome predicts gut microbiome alpha-diversity in humans. Nat Biotechnol. 2019;37(10):1217–1228. doi:10.1038/s41587-019-0233-9
  • Ahmed F, Brewington C, Chang KJ, Moreno CC, Gollub M, Yee J. Letter to the editor regarding: multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study). Gut. 2022;71(1):214–215. doi:10.1136/gutjnl-2021-324396
  • Gram-Kampmann EM, Hansen CD, Hugger MB, et al. Effects of a 6-month, low-carbohydrate diet on glycaemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes: an open-label randomized controlled trial. Diabetes Obes Metab. 2022;24(4):693–703. doi:10.1111/dom.14633